Why did PKY.AX stock rise today?

PKY.AX stock rose on 18 Feb 2026 due to higher-than-normal volume and investor focus on an upcoming earnings announcement. Market interest in healthcare AI names and short-term technical strength above the 50-day average also supported the move.

What is Meyka AI’s forecast for PKY.AX stock?

Meyka AI's forecast model projects a quarterly target of A$0.060 for PKY.AX stock and a monthly projection of A$0.020. These are model-based projections and not guarantees; they show wide potential upside or downside depending on catalysts.

What are the main risks for PKY.AX stock?

Key risks for PKY.AX stock include negative EPS of -0.01, tight liquidity with current ratio 0.77, high price-to-sales of 20.51, and binary trial outcomes that can swing sentiment rapidly.

How should traders monitor PKY.AX stock going forward?

Traders should watch volume, price relative to A$0.01838 (50-day) and A$0.02094 (200-day), upcoming earnings on 25 Feb 2026, and ASX announcements. Use stop-losses and size positions for high volatility.

AU Stocks

PKY.AX Pathkey.AI up 38.10% intraday on ASX 18 Feb 2026: catalysts to watch

ByHuzaifa Zahoor February 18, 2026February 18, 2026

PKY.AX stock jumped 38.10% intraday to A$0.029 on the ASX in Australia, led by a surge in volume of 5,521,447 shares as traders reacted to near-term catalysts. The move lifts Pathkey.AI Ltd (PKY.AX) well above its 50-day average of A$0.01838 and its 200-day average of A$0.02094. Market attention is focused on upcoming earnings and trial partnerships after the company rebranded in August 2025, and the stock’s relative strength today signals short-term momentum for active traders.